|
|
|
|
|
Topics
|
|
Glioblastoma
| Prognosis | Nomograms
|
|
|
|
|
|
Home
> Publications
> Topics
> Glioblastoma
>
Prognosis
>
Nomograms
|
|
|
|
|
Overall survival
|
Wang Y, Mu Q, Sheng M, Chen Y, Jian F, Li R.
A
Nomogram for Predicting Overall Survival of Patients With Primary
Spinal Cord Glioblastoma.
Neurospine.
2024 Jun 30;21(2):676-689. doi:
10.14245/ns.2448082.041. PMID:
38955537. Observational study. ˍ
|
|
|
Recurrence risk
|
*Gao L, Yuan T, Liu Y, Yang X, Li Y, Quan G.
Prognostic
nomogram model based on quantitative metrics of subregions
surrounding residual cavity in glioblastoma patients.
J
Cancer Res Clin Oncol. 2024 Nov 1;150(11):483. doi:
10.1007/s00432-024-06008-6. PMID:
39487262. Observational study. ˍ
|
|
|
Survival
outcomes at 6, 12, and 18
months
|
Shao Z, Yan H, Zhu M, Liu Z, Chen Z, Li W, Wang C, Zhang L, Zheng
J.
The impact of the subventricular
zone invasion types and MGMT methylation status on tumor
recurrence and prognosis in glioblastoma.
Heliyon.
2024 Nov 20;10(23):e40558. doi:
10.1016/j.heliyon.2024.e40558. PMID:
39687126. Observational study.
ˍ
|
|
|
Overall survival
|
Xu H, Jiang LH, Yu SN, Ren QL.
The
Prognostic Value of the Systemic Immune-Inflammation Index in
Glioblastoma Patients and the Establishment of a Nomogram.
Curr
Med Sci. 2025 Apr 16. doi:
10.1007/s11596-025-00047-x. PMID:
40240723. Observational study˰
ˍ
|
|
|
Overall survival
|
Mu Y, Luo J, Xiong T, Zhang J, Lan J, Zhang J, Tan Y, Yang S.
Development and validation of nomogram
model predicting overall survival and cancer specific survival in
glioblastoma patients. Discov
Oncol. 2025 Apr 18;16(1):562. doi:
10.1007/s12672-025-02331-7. PMID:
40249416. Observational study.
ˍ
|
|
|
|
|
|
|